CClinicalTrials.gg
RecruitingNCT04526600Updated Sep 15, 2026

Fidgeting and Attentional and Emotional Regulation in ADHD

An interventional study of Fidget ball in ADHD, sponsored by University of California, Davis. Recruiting at 1 site in United States. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by University of California, Davis · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
109
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This project will study how fidgeting relates to cognitive and emotional functioning in adults with attention-deficit/hyperactivity disorder (ADHD). It will determine, in a laboratory setting, whether movement and access to a "fidget device" providing sensory and motor stimulation can improve cognitive and emotional regulation (including on physiological measures) in adult ADHD. The investigators will also acquire pilot data for machine learning analyses to be used in future, large scale studies to identify gestures and touch characteristics associated with improved cognitive and emotional regulation to see if the data can predict and subsequently develop recommendations to improve performance and emotional control in natural settings (e.g., home, office, college classroom) for adult ADHD.

Read the detailed description

Fidgeting is a highly common behavior, with excessive fidgeting associated with attention-deficit/hyperactivity disorder (ADHD). Studies from the investigator's laboratory and colleagues suggest physical movement can enhance cognitive performance in children with ADHD. Hyper-sensorimotor behavior may be related to impaired regulation of arousal in the noradrenergic and dopaminergic systems. This project will assess if frequency and characteristics of sensorimotor behavior relates to cognitive and emotional response in adults with ADHD, in a fine-grained manner, unlike other studies. The investigators will test if intrinsic fidgeting (Aim 1) and access to a specially designed fidget device (Aim 2) modulates behavioral and physiological response in cognitively and emotionally-demanding contexts. The hype of the commercially available fidget devices, its competitors and fidget spinners suggest it might, but there is no systematic evidence to inform consumers, a gap, the investigators aim to fill.

02

Conditions studied

03

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ADHD
  • History of fidgeting

Exclusion criteria

Exclusion Criteria:

  • Currently taking psychoactive medication, with the exception of stimulant medication for ADHD or medication that can affect heart rate;
  • Presence of significant depression or psychotic disorders, autism, visual or hearing impairment or any other disorder that may interfere with task performance; and IQ below 85
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
109 participants (estimated)

Study arms

  • No intervention
    No fidget
  • Experimental
    With fidget

    The participant is given a specially designed fidget ball

    Other: Fidget ball

Interventions

  • OtherFidget ball

    Access to a prototype 'smart' fidget ball with pressure sensors embedded, that produces touch traces and transmits real time data

05

What researchers measure

Primary outcomes

  1. Processing speed

    Paced Auditory Serial Addition Task (PASAT)

    Time frame: Day 1

  2. Working memory

    List Sorting Test

    Time frame: Day 1

  3. Response inhibition

    Flanker type test

    Time frame: Day 1

Secondary outcomes

  1. Physiological response as an index of emotional regulation

    Heart rate variability and pre ejection period

    Time frame: Approximately 45 minutes

06

Study locations

1 of 1 sites recruiting
  • UC Davis MIND Institute
    Sacramento, California 95817, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — Data will be shared via NDAR

Supporting information: Study protocol

08

Registry details

Key details

Study ID
NCT04526600
Lead sponsor
University of California, Davis
Responsible party
Sponsor
First posted
Aug 26, 2020
Start date
Mar 21, 2022
Primary completion
Jul 1, 2024
Completion
Dec 1, 2026 (estimated)
Last update
Sep 15, 2026

Study contacts

Jared Borden
Contact
jborden@ucdavis.edu
916-703-0294
Julie Schweitzer, Ph.D.
principal investigator · UC Davis MIND Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion